| （単位：千ドル） | 2Q20 | 3Q20 | 1Q21 | 2Q21 | 3Q21 | 1Q22 | 2Q22 | 3Q22 | 1Q23 | 2Q23 | 3Q23 | 1Q24 | 2Q24 | 3Q24 | 1Q25 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 研究開発費 | 7,861 | 9,828 | 13,539 | 15,957 | 16,616 | 19,568 | 21,049 | 23,435 | 26,135 | 25,122 | 22,194 | 25,237 | 23,130 | 25,250 | 24,172 |
| 営業費用 | 10,355 | 13,746 | 19,481 | 21,634 | 22,428 | 26,098 | 27,612 | 30,262 | 34,313 | 36,858 | 29,294 | 32,762 | 30,715 | 33,794 | 36,564 |
| 営業利益 | -10,356 | -13,746 | -19,481 | -21,634 | -22,428 | -26,098 | -27,612 | -30,262 | -34,313 | -36,858 | -29,294 | -32,762 | -30,715 | -33,794 | -36,564 |
| 純利益 | -51,066 | -13,693 | -19,373 | -21,535 | -22,353 | -25,987 | -26,923 | -28,345 | -30,815 | -33,287 | -25,645 | -29,518 | -24,993 | -28,344 | -31,983 |
| 一株あたり利益 | - | - | - | - | - | - | -0.61 | -0.58 | -0.63 | -0.68 | -0.52 | -0.58 | -0.34 | -0.39 | -0.43 |
| 希薄化後一株あたり利益 | - | - | - | - | - | - | -0.61 | -0.58 | -0.63 | -0.68 | -0.52 | -0.58 | -0.34 | -0.39 | -0.43 |